August 3, 2022
MicroGen Diagnostics is growing its business for targeted sequencing-based orthopedic and urological infection detection on the heels of new contracts and outcomes studies…. the JBJS study showed the MicroGen test detected polymicrobial infections in a majority of cases that had shown no organism growth after standard microbial culture. Karan Goswami, first author on the JBJS study and a researcher at the Rothman Orthopaedic Institute in Philadelphia, said in an email that work marks “the largest cohort reporting the utility of NGS in isolating infective organisms in culture-negative cases.”
April 21, 2022
Next-generation sequencing: A reliable tool for the diagnosis and treatment of complicated and recurrent urinary tract infections
URINARY TRACT INFECTIONS (UTIs) are a common outpatient infection, especially in women aged over 65 years. At least 1 in 2 women will have a UTI in her lifetime. In all, 20% to 40% of these women will have 1 recurrence, and, of those, up to 50% will go on to have multiple recurrences.1,2 The gold-standard diagnostic tool for UTI is urine culture, a technology that relies upon the ability of the causative organism(s) to grow in artificial conditions. The problem with culture is that many organisms that cause symptomatic urinary tract infections will not grow on standard culture medium, […]
January 4, 2022
As COVID-19 cases continue to spike throughout the Roaring Fork Valley since the omicron variant made its presence known in mid-December….the Free COVID-19 Testing Roaring Fork Valley has announced that it will soon offer same-day results on all testing. “The service, in collaboration with MicroGenDX — a company specializing in low-cost, FDA-authorized, highly accurate qPCR + NGS microbial diagnostics — has set up a local lab processing center in Carbondale….the announcement explained.”
June 29, 2021
MicroGen Diagnostics has acquired its RTL Genomics partner lab to expand expertise and capacity in non-clinical primary research.
June 24, 2021
MicroGenDx said that it has acquired next-generation sequencing laboratory RTL Genomics. MicroGenDx, which provides sequencing- and PCR-based microbial testing for clinical diagnostic applications, said the deal would help expand its capabilities in nonclinical primary research. MicroGenDx said it has built a reference database of over 50,000 microbial species based on ITS and 16S sequencing and that the addition of RTL will help it create a similar database with whole-genome sequencing.